Sebia Acquires Zeus Scientific
Sebia has announced the acquisition of Zeus Scientific, an In Vitro Diagnostic (IVD) company based in New Jersey.
Read MorePosted by Chris Wolski | Oct 11, 2022 | Allergy & Autoimmune, Company News |
Sebia has announced the acquisition of Zeus Scientific, an In Vitro Diagnostic (IVD) company based in New Jersey.
Read MorePosted by Chris Wolski | Oct 10, 2022 | Prenatal Testing |
Diagnostic screening for Down’s Syndrome during pregnancy was difficult until the development of an NIPT fetal fraction test.
Read MorePosted by Chris Wolski | Oct 5, 2022 | Pancreatic, Sequencing Systems |
The PancreaSeq molecular test accurately classifies pancreatic cysts as potentially cancerous or benign, a large, multi-center study found.
Read MorePosted by Chris Wolski | Oct 5, 2022 | Miscellaneous |
SALSA legislation will help protect labs and patients by addressing the shortcomings of the 2014 Protecting Access to Medicare Act.
Read MorePosted by Andy Lundin | Sep 23, 2022 | Prostate |
A new study investigated genomic biomarkers associated with aggressive disease in African American men with prostate cancer.
Read More